“Smart” Software Emerging As Key To Artificial Pancreas For Diabetes Care
This article was originally published in The Gray Sheet
Executive Summary
The success of diabetes management technology leading to development of a closed-loop artificial pancreas will hinge on the incorporation of "intelligent" software than can adapt to individual patient needs, stakeholders say
You may also be interested in...
Medtronic Looks At Implantable Pancreas In Europe, Mulls U.S. Plans
Despite small glimpses of success with a fully implantable system to monitor glucose in a diabetic's bloodstream and automatically regulate insulin therapy, Medtronic is still mulling whether this approach will ultimately be the focus of its diabetes management program
Medtronic Looks At Implantable Pancreas In Europe, Mulls U.S. Plans
Despite small glimpses of success with a fully implantable system to monitor glucose in a diabetic's bloodstream and automatically regulate insulin therapy, Medtronic is still mulling whether this approach will ultimately be the focus of its diabetes management program
C-Path Institute Exec Targets “Points Of Pain” In Device Development
The Critical Path Institute's new Director of Medical Devices and Imaging, Ellen Feigal, MD, is working with device firms to identify key roadblocks to product development and clear the way to regulatory approval for those products